BRIDGEWAY CAPITAL MANAGEMENT, LLC

Holdings History for Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share (XLO)

Symbol: XLO on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$35,903	56,081	0		$0.64	Q4 2025
30 Sep 2025	0%	0%	$47,259	56,081	0		$0.84	Q3 2025
30 Jun 2025	0%	-0%	$38,129	56,081	-15,000	-21%	$0.68	Q2 2025
31 Mar 2025	0%	0%	$51,491	71,081	0		$0.72	Q1 2025
31 Dec 2024	0%	0%	$67,882	71,081	0		$0.95	Q4 2024
30 Sep 2024	0%	0%	$55,991	71,081	0		$0.79	Q3 2024
30 Jun 2024	0%	0%	$67,349	71,081	0		$0.95	Q2 2024
31 Mar 2024	0%	-0%	$76,767	71,081	-84,400	-54%	$1.08	Q1 2024
31 Dec 2023	0%	+0%	$85,515	155,481	+45,000	+41%	$0.55	Q4 2023
30 Sep 2023	0.01%	0%	$233,115	110,481	0		$2.11	Q3 2023
30 Jun 2023	0.01%	0%	$289,460	110,481	0		$2.62	Q2 2023
31 Mar 2023	0.01%	0%	$351,330	110,481	0		$3.18	Q1 2023
31 Dec 2022	0.01%	+0%	$297,194	110,481	+34,400	+45%	$2.69	Q4 2022
30 Sep 2022	0.01%	+0.01%	$221,000	76,081	+76,081	NEW	$2.90	Q3 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.